AKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium

From Prostate Cancer Update by Dr. Neil Love

March 31, 2026 · 1h 29m · Season 24 · Episode 36

About this episode

Experts discuss the future role of AKT inhibition in prostate cancer treatment.

Prof Karim Fizazi from the Centre Oscar Lambret in Lille, France, Dr Daniel George from the Duke Cancer Institute in Durham, North Carolina, and moderator Dr Elisabeth I Heath from Mayo Clinic in Rochester, Minnesota, discuss the future role of AKT inhibition in prostate cancer. CME information and select publications  here .

More episodes of Prostate Cancer Update

Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances · April 17, 2026 · 58 min
Metastatic Bladder Cancer — Rapid Case Review Issue 4 · April 15, 2026 · 28 min
Metastatic Bladder Cancer — Rapid Case Review Issue 3 · March 27, 2026 · 33 min
Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium · March 25, 2026 · 1h 58m
Urothelial Bladder Cancer — Microlearning Activity 2 with Dr Terence Friedlander: ESMO Congress 2025 Review · February 23, 2026 · 23 min
Metastatic Bladder Cancer — Rapid Case Review Issue 2 · February 17, 2026 · 29 min

Explore listener stats, chart rankings, contacts and more on the Prostate Cancer Update podcast page.